Abstract
The ability of the peptide cholecystokinin (CCK) to induce monocyte chemotaxis was tested both in vivo and in vitro. In the in vitro assay, the activity of different forms of CCK on human monocytes was studied demonstrating the importance of sulfation on tyrosine for the chemotactic activity. CCK receptor antagonists benzotript and CR-1369 are able to block CCK 8 sulfated chemotaxis, thus suggesting the presence of CCK receptors on human monocytes. In both acute and chronic experiments, the peptide specifically increases the number of peritoneal macrophages, when injected into rat peritoneal cavity. These data suggest that immune system cell migration from one body compartment to another can be produced by a neuropeptide receptor-mediated process.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
